ETON
Eton Pharmaceuticals, Inc.$64.03+0.10 (+0.16%)Prev Close$63.93·MCap$1.97B·P/E—·Vol409.7K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
19
$31.56M
◆
Net Activity
Net Seller
$31.56M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Eton Pharmaceuticals, Inc. (ETON) has been exclusively selling, with 0 insider purchases totaling $0.00 and 19 insider sales totaling $31.56M. The most recent insider transaction was by Erdogan-Trinkaus Ipek (officer: Chief Commercial Officer), who sold $235.9K worth of shares on Nov 12, 2026. Eton Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $1.97B.
ETON Insider Trading Activity
ETON Insider Buying Activity
The following table shows recent insider purchases of Eton Pharmaceuticals, Inc. (ETON) stock reported via SEC Form 4 filings.
ETON Insider Selling Activity
The following table shows recent insider sales of Eton Pharmaceuticals, Inc. (ETON) stock reported via SEC Form 4 filings.